GHK-Cu: Research Overview

GHK-Cu pairs a three-residue peptide, glycyl-L-histidyl-L-lysine, with a single copper(II) ion. The free peptide occurs naturally in human plasma, and its strong affinity for copper led biochemists to treat the metal complex, rather than the bare peptide, as the form worth studying. Five decades on, GHK-Cu is one of the most frequently cited copper peptides in matrix biology and coordination chemistry.

The research spans quite different questions: how a small peptide holds a transition metal, how fibroblasts respond to it in culture, and what large gene-expression datasets suggest about its activity. The sections below follow that path from discovery to current animal work, then set out what remains unproven.

At a glance

• Class: Copper(II) complex of a naturally occurring tripeptide
• Origin: GHK identified in human plasma by Loren Pickart and Martin Thaler in 1973 (Pickart and Thaler, 1973)
• Structure: Gly-His-Lys bound to Cu(II); C₁₄H₂₃CuN₆O₄; 402.92 g/mol; CAS 89030-95-5
• Main research areas: copper coordination chemistry, fibroblast matrix synthesis and remodeling, gene-expression analyses, rodent inflammation models
• Regulatory status: Not an FDA-approved drug; used as a cosmetic ingredient, while the lyophilized material sold here is a research reagent

Structure and origin

The peptide came to light in studies of plasma factors that affect cultured liver tissue. Pickart and Thaler traced part of that activity to a small tripeptide that extended survival of normal hepatocytes and stimulated growth of hepatoma cells (Pickart and Thaler, 1973). Its identity as Gly-His-Lys, and its tendency to carry copper, were worked out over the following years.

Lau and Sarkar characterized the copper interaction in solution, describing the species that form at physiological pH (Lau and Sarkar, 1981). In the dominant complex, Cu(II) is coordinated by three nitrogen atoms from the peptide: the free amino group of glycine, the deprotonated amide nitrogen linking glycine to histidine, and a nitrogen of the histidine imidazole ring. The lysine side chain does not take part in that core binding site, which leaves its positively charged amine free to interact with other molecules. Later X-ray work compared the GHK complex with copper bound to Asp-Ala-His-Lys, the N-terminal sequence of human serum albumin, and related the different geometries to differences in Cu(II)/Cu(I) redox behavior (Hureau et al., 2011).

Because the binding constant is high, GHK can take copper from weaker carriers. That property is the basis of a long-standing hypothesis that the peptide helps deliver copper to cells, a question still discussed in reviews (Pickart, 2008).

Mechanism: what the research shows

No single receptor for GHK-Cu has been identified. The published mechanistic picture is assembled from three kinds of evidence.

The first is metal chemistry. Copper is a cofactor for enzymes involved in connective tissue and antioxidant defense, including lysyl oxidase and superoxide dismutase, so a peptide that carries copper in a soluble, relatively non-reactive form could influence those pathways indirectly. The second is direct cell-culture work. Maquart and colleagues added GHK-Cu to fibroblast cultures and measured increased collagen synthesis (Maquart et al., 1988). A later study from the same research tradition found increased expression of matrix metalloproteinase-2, an enzyme that degrades collagen, along with changes in its tissue inhibitors (Siméon et al., 2000). Together these results suggested a role in both building and remodeling matrix rather than simple stimulation.

The third is computational. Pickart and Margolina reviewed analyses of public gene-expression datasets, including the Broad Institute’s Connectivity Map, in which GHK was associated with shifts in the expression of large gene sets linked to repair, antioxidant responses and inflammation (Pickart and Margolina, 2018). These are correlations in cell-line data and serve as hypotheses, not demonstrated mechanisms.

Key areas of study

Coordination and redox chemistry

GHK-Cu is a standard model for how short peptides with histidine in the second position bind copper. Spectroscopy, titration and crystallography are used to compare it with other copper-binding motifs, especially the albumin-type sequence in which histidine sits third (Lau and Sarkar, 1981; Hureau et al., 2011).

Fibroblast and matrix biology

Cultured fibroblasts are the classic in-vitro system. Readouts include collagen and glycosaminoglycan production and the expression of matrix metalloproteinases and their inhibitors (Maquart et al., 1988; Siméon et al., 2000).

Gene-expression analyses

Database studies have been used to generate hypotheses about which pathways GHK touches. Because the Connectivity Map data come from a few cancer cell lines, the relevance of these patterns to other cell types is uncertain (Pickart and Margolina, 2018).

Rodent inflammation models

Recent animal work has moved into inflammation. In an experimental rodent colitis model, Mao and colleagues examined oxidative-stress and inflammatory signaling readouts after GHK-Cu treatment (Mao et al., 2025). This is a single study and awaits replication.

What the evidence does not show

• The core findings come from cell culture and rodent models. They do not establish any effect in humans.
• No specific receptor has been identified, so the mechanism remains a composite of copper chemistry, culture data and gene-expression correlations.
• Many studies use the free peptide, others the copper complex; results for one form cannot be assumed for the other.
• A large share of the review literature comes from a small number of authors, and some proposed roles rest on database analyses rather than direct experiments.
• Use of GHK-Cu as a cosmetic ingredient does not make it an approved drug, and it says nothing about the research reagent sold here.

Regulatory status

GHK-Cu is not approved by the FDA as a drug. It appears as an ingredient in some topical cosmetic products. The lyophilized GHK-Cu sold by Rogue Compounds is a research reagent, not a cosmetic or drug product, and is not for human use.

Handling and storage in the lab

Lyophilized GHK-Cu should be kept sealed and refrigerated at 2–8°C (36–46°F), protected from light.

Sourcing and documentation

Rogue Compounds has GHK-Cu made in small batches. Every vial carries a batch number and a QR code that opens the independent U.S. testing lab’s own report for that batch, and the same batch COA is on the product page and in the COA Library.

View GHK-Cu on Rogue Compounds

References

1. Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-87. PMID 4349963
2. Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J. 1981;199(3):649-656. PMID 7340824
3. Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346. PMID 3169264
4. Siméon A, et al. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257-2265. PMID 11045606
5. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. PMID 18644225
6. Hureau C, et al. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry. 2011;17(36):10151-10160. PMID 21780203
7. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PMID 29986520
8. Mao S, et al. Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms. Front Pharmacol. 2025;16:1551843. PMID 40672369

Research use only. Rogue Compounds products are sold strictly for laboratory research. They are not for human or veterinary use, and nothing in this article is medical advice. The studies cited here describe published research, not this product or any use of it.